Navigation Links
Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients
Date:12/9/2010

rin expression has been shown preclinically to increase sensitivity to EGFR inhibitors thereby restoring sensitivity to the standard of care treatment. E-cadherin, which can be measured easily in tumors, is therefore a potentially relevant clinical biomarker to select patients for treatment with erlotinib plus entinostat."

The primary endpoint of the study was four-month progression free survival rate with progression free survival (PFS) and overall survival (OS) as additional endpoints. In the unselected patient population made up of 132 evaluable patients, entinostat plus erlotinib appeared comparable in terms of PFS and survival. In the E-cadherin high sub-group (N = 26), entinostat plus erlotinib was associated with improved PFS and survival. The median PFS for the patients in the E-cadherin high

group treated with entinostat and erlotinib was 3.7 months vs. 1.9 months for the group treated with placebo and erlotinib (Hazard ratio 0.55) with a p-value of 0.19. The median survival was 9.4 months in the subgroup treated with entinostat and erlotinib vs. 5.4 months for those treated with placebo and erlotinib (Hazard ratio 0.36) with a p-value of 0.03.

Entinostat/erlotinib was tolerable with no unexpected adverse events and a manageable safety profile.

"Directing therapy based on the individual biology of a patient's tumor is finally driving better outcomes for patients with lung cancer," said Joanna Horobin, M.D., president and chief executive officer of Syndax. "Having seen improvement in PFS and overall survival in patients with tumors expressing high levels of e-cadherin who received entinostat and erlotinib, we now have a clear path forward. We look to add to treatment options as we evaluate entinostat with erlotinib in further randomized studies to be initiated next year in a selected patient population of NSCLC patients with high levels of E-cadherin."

The abstract "Molecular Analysis Identifies A Subset Of Non-small C
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
2. Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
3. Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... CAMBRIDGE, Mass. , Oct. 22, 2014 ... Cambridge, MA is revolutionizing spinal cord ... technique has been shown to outperform in tissue regrowth ... with the scaffold.  Made from an FDA approved polymer, ... dioxide; making it harmless to the human body. NVIV ...
(Date:10/22/2014)... and AUSTIN, Texas , Oct. ... LLC today announced they have entered into a ... immunotherapies designed to target cancers. PhosImmune ... displayed on the surfaces of tumor cells in ... (PTTs), derived from proteins that play a role ...
(Date:10/22/2014)... Oct. 22, 2014  Recently published clinical studies of ... already substantial database of evidence. This data has led ... Stretta therapy for sufferers of refractory GERD. ... supporting Stretta therapy as a safe and effective ... Stretta therapy available to nearly 50 million Americans. The ...
Breaking Medicine Technology:InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2
... Reportlinker.com announces that a new market research report ... Global Vertebral Compression Fracture Devices Industry ... analyzes the Global market for Vertebral Compression Fracture ... are provided for the period 2006 through 2015. ...
... that a new market research report is available in ... http://www.reportlinker.com/p0155051/Antidiabetics-market-forecast.html ... billion in 2019 for the seven major markets. Januvia ... expiry of Actos, with franchise sales reaching nearly $6 ...
Cached Medicine Technology:Reportlinker Adds Global Vertebral Compression Fracture Devices Industry 2Reportlinker Adds Global Vertebral Compression Fracture Devices Industry 3Reportlinker Adds Global Vertebral Compression Fracture Devices Industry 4Reportlinker Adds Global Vertebral Compression Fracture Devices Industry 5Reportlinker Adds Antidiabetics Market Forecast 2
(Date:10/22/2014)... Healthcare professionals who are looking ... at home or on-the-go via laptops, tablets or ... new, premium Seminar-on-Demand CE courses. The new courses ... 2,000 hours of CE course offerings, allowing ... With such a diverse library, there’s something for ...
(Date:10/22/2014)... 22, 2014 Richard Carlson, Managing Partner ... leader with over 25 years experience. Mr. Carlson ... the areas related to EDI, B2B Commerce, RFID and ... Editorial Advisory Board member for Pharmaceutical Commerce Magazine and ... Fin Group is a management and technology consulting firm ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... By Dennis Thompson ... -- U.S. health officials on Monday officially tightened guidelines for ... with no skin exposure and use of a respirator at ... Prevention decided to issue the tougher rules after two Dallas ... diagnosed in the United States, Liberian national Thomas Eric Duncan. ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Allegheny General ... procedure that enables physicians to repair a damaged mitral ... MitraClip system, developed by Abbott Vascular ... a progressive and life-threatening condition in which the heart’s ... to flow backward from the heart’s left ventricle into ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
... third of women surveyed about their beliefs surrounding miscarriage and ... mood could negatively affect her baby. , One in ... upsetting situations could hurt her unborn child, and one in ... , Despite those beliefs, relatively few of the women ...
... The preterm birth rate rose again in 2005 and preliminary ... need for a sustained, comprehensive plan to address this growing ... consequences of an early birth, the more determined the March ... how it can be prevented, said Dr. Jennifer L. Howse, ...
... A new study recently published in the Journal of Cosmetic ... slenderizing thighs. , The Brazilian researchers studied 99 women treated ... solution. The women used the cream twice daily for 30 ... at the end of the study, the slimming effect was ...
... FORT WORTH, Texas, Dec. 6 A Tarrant County ... 75-year-old Fort Worth man who,died after his physician failed ... six hours over two days before issuing their,verdict on ... W. Lowe III.,The jury found that Dr. Paul J. ...
... Dispensed $24 Million Worth of,Prescription Drugs Through Rogue ... Luxury Lifestyle, Including Seven,Convertibles, Four Stretch Limousines & ... The National Health,Care Anti-Fraud Association (NHCAA) today is ... Services, and Treasury the 2007,Fraud "Investigation of the ...
... to Fix Flaws in Medicaid Generic Prescription,Drug System, ... pharmacy owners held a press conference at Capital ... Mitch McConnell,(R-Ky.) to help ensure S.1951, the Fair ... the Senate floor for a vote before they ...
Cached Medicine News:Health News:Miscarriage myths persist despite prevalence of medical information 2Health News:Miscarriage myths persist despite prevalence of medical information 3Health News:Miscarriage myths persist despite prevalence of medical information 4Health News:Jury Awards $5.25 Million Malpractice Verdict Against Fort Worth Doctor 2Health News:NHCAA Presents 2007 Fraud 'Investigation of the Year' Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy 'Drug Kingpin' 2Health News:NHCAA Presents 2007 Fraud 'Investigation of the Year' Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy 'Drug Kingpin' 3Health News:Kentucky Pharmacists Urge Senator McConnell to Put Patients First 2Health News:Kentucky Pharmacists Urge Senator McConnell to Put Patients First 3
Extremely fine straight....
Micro-Scissors "micro 2000". 12 mm, straight, extra-wide serrated handles....
Micro 2000 suture forceps light-weight instruments with blue-colored anodized round handles, extremely light weight, well balanced, easy to handle, fatigueless working, easy to maintain, corrosion-re...
Round tip, sharp all around, angled....
Medicine Products: